Therapeutic Links Between Anti-Cancer Drugs (Bexarotene) and Alzheimer’s Disease (original) (raw)

Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers

Lynne Waddington

Protein Engineering Design and Selection, 2008

View PDFchevron_right

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model

Hanna Lindberg

Frontiers in Aging Neuroscience, 2019

View PDFchevron_right

An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease

Dag Sehlin

Neurobiology of Disease, 2009

View PDFchevron_right

Immunotherapeutic Strategies for Alzheimer's Disease Treatment

Beka Solomon

The Scientific World JOURNAL, 2009

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-� from the inside

Beka Solomon

Trends Immunol, 2007

View PDFchevron_right

Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Luka Kulic

PLoS ONE, 2011

View PDFchevron_right

Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model

Ken-ichiro Fukuchi

Biochemical and Biophysical Research Communications, 2006

View PDFchevron_right

Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice

Thomas Wisniewski

The American Journal of Pathology, 2001

View PDFchevron_right

Amyloid-β Immunotherapy for Alzheimers Disease

Cynthia Lemere

Cns & Neurological Disorders-drug Targets, 2010

View PDFchevron_right

Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward

Andrea Santamato

Expert Review of Clinical Immunology, 2014

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-β from the inside

Beka Solomon

Trends in Immunology, 2007

View PDFchevron_right

P.3.10 Aβ Affitopes as active vaccines in the treatment of Alzheimer's diasease: preliminary results of two phase I studies

Eduard Auff

European Neuropsychopharmacology, 2009

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-â from the inside

Beka Solomon

Trends in Immunology, 2007

View PDFchevron_right

Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease

Sandra Villegas

mAbs, 2013

View PDFchevron_right

Amyloid-β Immunotherapy on Alzheimer disease: Prevention and Therapeutic Target

Opeyemi Adeloye

Journal of dermatology research and review, 2020

View PDFchevron_right

An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β Derivatives

Thomas Wisniewski

The Journal of Neuroscience, 2004

View PDFchevron_right

Immunotherapy for Alzheimer's disease

Thomas Wisniewski

Biochemical Pharmacology, 2014

View PDFchevron_right

Murine models of Alzheimer's disease and their use in developing immunotherapies

Thomas Wisniewski

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010

View PDFchevron_right

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

kim weiss

Nature Medicine, 2000

View PDFchevron_right

Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer’s disease

Annie Sun

Brain, Behavior, and Immunity, 2010

View PDFchevron_right

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-�� derivatives

Ayodeji Asuni

2004

View PDFchevron_right

Antibody therapy for Alzheimer's disease

Takeshi Tabira

Clinical Genetics, 1999

View PDFchevron_right

Amyloid-β immunisation for Alzheimer's disease

Thomas Wisniewski

The Lancet Neurology, 2008

View PDFchevron_right

Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice

Cynthia Lemere

Neurochemical research, 2003

View PDFchevron_right

Alzheimer disease immunotherapeutics: Then and now

Jagbir Malik

Human vaccines & immunotherapeutics, 2014

View PDFchevron_right

Immunological Approach for the Treatment of Alzheimer's Disease

Beka Solomon

Journal of Molecular Neuroscience, 2003

View PDFchevron_right

Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid β-related Behavioral Deficits in a Mouse Model of Alzheimer Disease

Kelly Johnson-wood

Journal of Biological Chemistry, 2009

View PDFchevron_right

Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model

Sudhir Paul

Journal of Alzheimer's disease : JAD, 2011

View PDFchevron_right

Epitope and isotype specificities of antibodies to -amyloid peptide for protection against Alzheimer's disease-like neuropathology

minh nguyen

Proceedings of The National Academy of Sciences, 2003

View PDFchevron_right